{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:02:37Z","timestamp":1793638957317,"version":"4.5.1"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001502","name":"Government of India Department of Atomic Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001502","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DST\/SJF\/LSA-02\/2017-18"],"award-info":[{"award-number":["DST\/SJF\/LSA-02\/2017-18"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR52628\/MED\/30\/2553\/2024"],"award-info":[{"award-number":["BT\/PR52628\/MED\/30\/2553\/2024"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology","doi-asserted-by":"publisher","award":["CRG\/2022\/005052"],"award-info":[{"award-number":["CRG\/2022\/005052"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bbrc.2026.153656","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:01:20Z","timestamp":1774512080000},"page":"153656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Epigenetic rewiring and T cell exhaustion in HBV-induced HCC with implications for precision therapies"],"prefix":"10.1016","volume":"815","author":[{"given":"Md Wasim Akram Ddoza","family":"Hazari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhik","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrima","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10127","key":"10.1016\/j.bbrc.2026.153656_bib1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.bbrc.2026.153656_bib2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bbrc.2026.153656_bib3","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the global burden of disease study 2019","volume":"7","author":"Sheena","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib4","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","article-title":"Mechanisms of HBV-Induced hepatocellular carcinoma","volume":"64","author":"Levrero","year":"2016","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2024.2421231","article-title":"Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma","volume":"15","author":"Zhang","year":"2024","journal-title":"Virulence"},{"issue":"5","key":"10.1016\/j.bbrc.2026.153656_bib6","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.immuni.2016.04.008","article-title":"Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission","volume":"44","author":"Tian","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/hep.31231","article-title":"Hepatitis B virus-telomerase reverse transcriptase promoter integration harnesses host ELF4, resulting in telomerase reverse transcriptase gene transcription in hepatocellular carcinoma","volume":"73","author":"Sze","year":"2021","journal-title":"Hepatology (Baltimore, Md"},{"issue":"26","key":"10.1016\/j.bbrc.2026.153656_bib8","doi-asserted-by":"crossref","first-page":"14707","DOI":"10.1073\/pnas.94.26.14707","article-title":"Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis","volume":"94","author":"Elmore","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"11","key":"10.1016\/j.bbrc.2026.153656_bib9","article-title":"Landscape of T-cell exhaustion heterogeneity and HBV integration in virus-related HCC revealed by whole-exome, transcriptome, and single-cell sequencing","volume":"7","author":"Lee","year":"2025","journal-title":"JHEP Rep."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153656_bib10","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1053\/j.gastro.2021.06.008","article-title":"Evidence-based management of hepatocellular carcinoma: systematic review and meta-analysis of randomized controlled trials (2002\u20132020)","volume":"161","author":"Haber","year":"2021","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.bbrc.2026.153656_bib11","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.4254\/wjh.v7.i8.1064","article-title":"Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues","volume":"7","author":"Rapti","year":"2015","journal-title":"World J. Hepatol."},{"issue":"3\u20134","key":"10.1016\/j.bbrc.2026.153656_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000360947","article-title":"Genotypes and genetic variability of hepatitis B virus","volume":"57","author":"Kramvis","year":"2014","journal-title":"Intervirology"},{"issue":"10","key":"10.1016\/j.bbrc.2026.153656_bib13","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/liv.13129","article-title":"Incidence of hepatocellular carcinoma according to hepatitis B virus genotype in Alaska native people","volume":"36","author":"Ching","year":"2016","journal-title":"Liver Int."},{"issue":"1 Suppl","key":"10.1016\/j.bbrc.2026.153656_bib14","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jhep.2016.01.027","article-title":"Overview of hepatitis B viral replication and genetic variability","volume":"64","author":"Tong","year":"2016","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153656_bib15","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/jvh.13273","article-title":"Long-term evolution of hepatitis B virus genotype F: strong association between viral diversification and the prehistoric settlement of central and South America","volume":"27","author":"Mojsiejczuk","year":"2020","journal-title":"J. Viral Hepat."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijmmb.2021.01.002","article-title":"Molecular characterization of hepatitis B virus reveals circulation of multiple subgenotypes of genotype D with clinically important mutations in central India","volume":"39","author":"Shivlata","year":"2021","journal-title":"Indian J. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-32865-1","article-title":"Mapping hepatitis B virus genotypes on the African continent from 1997 to 2021: a systematic review with meta-analysis","volume":"13","author":"Kafeero","year":"2023","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bbrc.2026.153656_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102573","article-title":"Distinct distribution pattern of hepatitis B virus genotype C and D in liver tissue and serum of dual genotype infected liver cirrhosis and hepatocellular carcinoma patients","volume":"9","author":"Datta","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153656_bib19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbrc.2008.07.115","article-title":"A1762T\/G1764A mutations of hepatitis B virus, associated with the increased risk of hepatocellular carcinoma, reduce basal core promoter activities","volume":"374","author":"Dong","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/gut.2007.119859","article-title":"Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B\/C, specific mutations of enhancer II\/core promoter\/precore regions and HBV DNA levels","volume":"57","author":"Yuen","year":"2008","journal-title":"Gut"},{"issue":"23","key":"10.1016\/j.bbrc.2026.153656_bib21","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.3748\/wjg.v22.i23.5393","article-title":"Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma","volume":"22","author":"Lee","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.bbrc.2026.153656_bib22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.virs.2023.06.004","article-title":"HBV precore G1896A mutation promotes growth of hepatocellular carcinoma cells by activating ERK\/MAPK pathway","volume":"38","author":"Zhao","year":"2023","journal-title":"Virol. Sin."},{"issue":"13","key":"10.1016\/j.bbrc.2026.153656_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133274","article-title":"HBV preS mutations promote hepatocarcinogenesis by inducing endoplasmic reticulum stress and upregulating inflammatory signaling","volume":"14","author":"Liu","year":"2022","journal-title":"Cancers"},{"issue":"31","key":"10.1016\/j.bbrc.2026.153656_bib24","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.3748\/wjg.v18.i31.4071","article-title":"Inflammation- and stress-related signaling pathways in hepatocarcinogenesis","volume":"18","author":"Hayato","year":"2012","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153656_bib25","first-page":"921","article-title":"Hepatitis B virus DNA integration drives carcinogenesis and provides a new biomarker for HBV-related HCC","volume":"15","author":"Yeh","year":"2023","journal-title":"CMGH"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153656_bib26","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1053\/j.gastro.2007.01.034","article-title":"Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein","volume":"132","author":"Park","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12011-015-0290-y","article-title":"Reduction of oxidative damage and inflammatory response in the diaphragm muscle of mdx mice using iron chelator deferoxamine","volume":"167","author":"Moraes","year":"2015","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.bbrc.2026.153656_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00849","article-title":"Pathogenetic mechanisms of T cell dysfunction in chronic HBV infection and related therapeutic approaches","volume":"11","author":"Fisicaro","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153656_bib29","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/hep.27732","article-title":"DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma","volume":"61","author":"Villanueva","year":"2015","journal-title":"Hepatology (Baltimore, Md"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16202","article-title":"HBV-induced carcinogenesis: mechanisms, correlation with viral suppression, and implications for treatment","volume":"45","author":"Tu","year":"2025","journal-title":"Liver Int. : off. J. Int. Assoc. Study Liver"},{"issue":"9","key":"10.1016\/j.bbrc.2026.153656_bib31","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1172\/JCI31457","article-title":"Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma","volume":"117","author":"Calvisi","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib32","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/hep.23247","article-title":"Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region- containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma","volume":"51","author":"Zhao","year":"2010","journal-title":"Hepatology (Baltimore, Md"},{"issue":"6","key":"10.1016\/j.bbrc.2026.153656_bib33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/1947601910393957","article-title":"DNA methylation: superior or subordinate in the epigenetic hierarchy?","volume":"2","author":"Jin","year":"2011","journal-title":"Genes Cancer"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153656_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.canlet.2012.01.038","article-title":"Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma","volume":"342","author":"Pogribny","year":"2014","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.canlet.2009.02.015","article-title":"Knockdown of SMYD3 by RNA interference down-regulates c-Met expression and inhibits cells migration and invasion induced by HGF","volume":"280","author":"Zou","year":"2009","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153656_bib36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12032-008-9144-1","article-title":"Hepatitis B virus X protein upregulates expression of SMYD3 and C-MYC in HepG2 cells","volume":"26","author":"Yang","year":"2009","journal-title":"Med. Oncol. (Northwood, London, England)"},{"issue":"18","key":"10.1016\/j.bbrc.2026.153656_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22189858","article-title":"Mechanisms of DNA methylation in virus-host interaction in hepatitis B infection: pathogenesis and oncogenetic properties","volume":"22","author":"Zhang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bbrc.2026.153656_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-04009-8","article-title":"SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"18","key":"10.1016\/j.bbrc.2026.153656_bib39","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.3748\/wjg.v23.i18.3252","article-title":"Hepatitis B virus X protein induces hepatic stem cell-like features in hepatocellular carcinoma by activating KDM5B","volume":"23","author":"Wang","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"14","key":"10.1016\/j.bbrc.2026.153656_bib40","doi-asserted-by":"crossref","first-page":"12723","DOI":"10.18632\/oncotarget.3713","article-title":"JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN\/AKT signaling in hepatocellular carcinoma cells","volume":"6","author":"Tang","year":"2015","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.bbrc.2026.153656_bib41","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1021\/acsinfecdis.4c00213","article-title":"UBR7 E3 ligase suppresses Interferon-\u03b2 mediated immune signaling by targeting Sp110 in hepatitis B virus-induced hepatocellular carcinoma","volume":"10","author":"Singh","year":"2024","journal-title":"ACS Infect. Dis."},{"issue":"50","key":"10.1016\/j.bbrc.2026.153656_bib42","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M117.796839","article-title":"Host transcription factor speckled 110 kDa (Sp110), a nuclear body protein, is hijacked by hepatitis B virus protein X for viral persistence","volume":"292","author":"Sengupta","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bbrc.2026.153656_bib43","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nri3088","article-title":"Transcriptional regulation of macrophage polarization: enabling diversity with identity","volume":"11","author":"Lawrence","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"JUN","key":"10.1016\/j.bbrc.2026.153656_bib45","article-title":"Chromatin architecture as an essential determinant of dendritic cell function","volume":"10","author":"Boukhaled","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cell.2013.03.004","article-title":"Influence of metabolism on epigenetics and disease","volume":"153","author":"Kaelin","year":"2013","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.bbrc.2026.153656_bib47","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"7779","key":"10.1016\/j.bbrc.2026.153656_bib48","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153656_bib49","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/bjc.2015.170","article-title":"miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells","volume":"113","author":"Higashi","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.bbrc.2026.153656_bib50","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190615","article-title":"LncRNA SAMMSON negatively regulates miR-9-3p in hepatocellular carcinoma cells and has prognostic values","volume":"39","author":"Yang","year":"2019","journal-title":"Biosci. Rep."},{"issue":"11","key":"10.1016\/j.bbrc.2026.153656_bib51","first-page":"4041","article-title":"Overexpression of MiR-452-5p in hepatocellular carcinoma tissues and its prospective signaling pathways","volume":"12","author":"Rong","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153656_bib52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2217\/pme-2020-0027","article-title":"MiR-452-5p mediates the proliferation, migration and invasion of hepatocellular carcinoma cells via targeting COLEC10","volume":"18","author":"Zheng","year":"2021","journal-title":"Pers. Med."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib53","article-title":"MiR-494-3p promotes PI3K\/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN","volume":"8","author":"Lin","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bbrc.2026.153656_bib54","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1158\/0008-5472.CAN-18-1675","article-title":"miR-192-5p silencing by genetic aberrations is a key event in hepatocellular carcinomas with cancer stem cell features","volume":"79","author":"Gu","year":"2019","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153656_bib55","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1080\/21655979.2022.2049472","article-title":"Long non-coding RNA HAGLROS facilitates tumorigenesis and progression in hepatocellular carcinoma by sponging miR-26b-5p to up-regulate karyopherin \u03b12 (KPNA2) and inactivate p53 signaling","volume":"13","author":"Tang","year":"2022","journal-title":"Bioengineered"},{"issue":"21","key":"10.1016\/j.bbrc.2026.153656_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/cells11213466","article-title":"Identification and verification of a novel MAGI2-AS3\/miRNA-374-5p\/FOXO1 network associated with HBV-related HCC","volume":"11","author":"Wang","year":"2022","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.bbrc.2026.153656_bib57","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jhep.2015.06.023","article-title":"HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase","volume":"63","author":"Rivi\u00e8re","year":"2015","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.bbrc.2026.153656_bib58","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1074\/jbc.M606774200","article-title":"The hepatitis B virus X protein functionally interacts with CREB-binding protein\/p300 in the regulation of CREB-mediated transcription","volume":"282","author":"Cougot","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"205","key":"10.1016\/j.bbrc.2026.153656_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2001906","article-title":"Inhibition of PP1 phosphatase activity by HBx: a mechanism for the activation of hepatitis B virus transcription","volume":"5","author":"Cougot","year":"2012","journal-title":"Sci. Signal."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153656_bib60","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/hep.25781","article-title":"Subset of Suz12\/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein","volume":"56","author":"Studach","year":"2012","journal-title":"Hepatology (Baltimore, Md"},{"issue":"6","key":"10.1016\/j.bbrc.2026.153656_bib61","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/onc.2015.122","article-title":"Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2","volume":"35","author":"Fan","year":"2016","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153656_bib62","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jhep.2008.10.019","article-title":"Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A","volume":"50","author":"Zheng","year":"2009","journal-title":"J. Hepatol."},{"issue":"SUPPL. 1","key":"10.1016\/j.bbrc.2026.153656_bib63","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1440-1746.2010.06546.x","article-title":"Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma","volume":"26","author":"Kew","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.bbrc.2026.153656_bib64","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.2174\/13816128113199990533","article-title":"Epigenetic mechanism involved in the HBV\/HCV-related hepatocellular carcinoma tumorigenesis","volume":"20","author":"Rongrui","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"7","key":"10.1016\/j.bbrc.2026.153656_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09881","article-title":"Hepatitis B virus X protein and hepatitis C virus core protein cooperate to repress E-cadherin expression via DNA methylation","volume":"8","author":"Yoon","year":"2022","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153656_bib66","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12079-021-00645-z","article-title":"Hepatitis B virus x gene-downregulated growth-arrest specific 5 inhibits the cell viability and invasion of hepatocellular carcinoma cell lines by activating Y-box-binding protein 1\/p21 signaling","volume":"16","author":"Yu","year":"2022","journal-title":"J. Cell Commun. Signal."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153656_bib67","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ijc.28697","article-title":"Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway","volume":"135","author":"Xie","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.bbrc.2026.153656_bib68","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.7150\/thno.48739","article-title":"Hypermethylation of GNA14 and its tumor-suppressive role in hepatitis B virus-related hepatocellular carcinoma","volume":"11","author":"Song","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib69","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41388-020-01498-3","article-title":"Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression","volume":"40","author":"Yan","year":"2021","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib70","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.18632\/oncotarget.13586","article-title":"Molecular mechanism of hepatitis B virus (HBV) on suppression of raf kinase inhibitor protein (RKIP) expression","volume":"8","author":"Cheng","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.bbrc.2026.153656_bib71","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/ijc.31816","article-title":"JMJD6 promotes hepatocellular carcinoma carcinogenesis by targeting CDK4","volume":"144","author":"Wan","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.bbrc.2026.153656_bib72","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1053\/jhep.2002.35342","article-title":"Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, \u03b2-catenin expression, and clinical features","volume":"36","author":"Wei","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib73","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-016-0441-9","article-title":"RAR\u03b3-induced E-cadherin downregulation promotes hepatocellular carcinoma invasion and metastasis","volume":"35","author":"Gan","year":"2016","journal-title":"J. Exp. Clin. Cancer Res. : CR"},{"key":"10.1016\/j.bbrc.2026.153656_bib74","doi-asserted-by":"crossref","first-page":"8947","DOI":"10.2147\/CMAR.S225606","article-title":"Genetic and epigenetic regulation of e-cadherin signaling in human hepatocellular carcinoma","volume":"11","author":"Fan","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib75","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.virusres.2008.09.006","article-title":"Hepatitis B virus-X protein recruits histone deacetylase 1 to repress insulin-like growth factor binding protein 3 transcription","volume":"139","author":"Shon","year":"2009","journal-title":"Virus Res."},{"issue":"34","key":"10.1016\/j.bbrc.2026.153656_bib76","doi-asserted-by":"crossref","first-page":"29540","DOI":"10.1074\/jbc.M111.263111","article-title":"Involvement of insulin-like growth factor-binding protein-3 in the effects of histone deacetylase inhibitor MS-275 in hepatoma cells","volume":"286","author":"Lin","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.153656_bib77","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2147\/CMAR.S234291","article-title":"IGFBP-3 is the key target of sanguinarine in promoting apoptosis in hepatocellular carcinoma","volume":"12","author":"Wang","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"7","key":"10.1016\/j.bbrc.2026.153656_bib78","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41419-022-05094-z","article-title":"SALIS transcriptionally represses IGFBP3\/Caspase-7-mediated apoptosis by associating with STAT5A to promote hepatocellular carcinoma","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.bbrc.2026.153656_bib79","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.3892\/ol.2017.5934","article-title":"Low expression levels of insulin-like growth factor binding protein-3 are correlated with poor prognosis for patients with hepatocellular carcinoma","volume":"13","author":"Yan","year":"2017","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib80","doi-asserted-by":"crossref","DOI":"10.1186\/s12864-017-3561-5","article-title":"Genome-wide identification of direct HBx genomic targets","volume":"18","author":"Guerrieri","year":"2017","journal-title":"BMC Genom."},{"issue":"10","key":"10.1016\/j.bbrc.2026.153656_bib81","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1093\/nar\/gku260","article-title":"Modulation of HBV replication by microRNA-15b through targeting hepatocyte nuclear factor 1\u03b1","volume":"42","author":"Dai","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib82","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-023-03002-9","article-title":"EZH2-mediated epigenetic silencing of tumor-suppressive let-7c\/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis","volume":"23","author":"Wu","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"15","key":"10.1016\/j.bbrc.2026.153656_bib83","first-page":"7533","article-title":"HBx promotes hepatocellular carcinoma progression by repressing the transcription level of miR-187-5p","volume":"15","author":"Deng","year":"2023","journal-title":"Aging"},{"issue":"3","key":"10.1016\/j.bbrc.2026.153656_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100688","article-title":"HBX suppresses PTEN to promote the malignant progression of hepatocellular carcinoma through mi-R155 activation","volume":"27","author":"Niu","year":"2022","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153656_bib85","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.omtn.2022.05.031","article-title":"Upregulation of miR-520c-3p via hepatitis B virus drives hepatocellular migration and invasion by the PTEN\/AKT\/NF-\u03baB axis","volume":"29","author":"Liu","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bbrc.2026.153656_bib86","article-title":"Upregulation of miR-3130-5p enhances hepatocellular carcinoma growth by suppressing ferredoxin 1 : miR-3130-5p enhances HCC growth via inhibiting FDX1","volume":"17","author":"Xu","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"16","key":"10.1016\/j.bbrc.2026.153656_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202103135","article-title":"LINC01431 promotes histone H4R3 methylation to impede HBV covalently closed circular DNA transcription by stabilizing PRMT1","volume":"9","author":"Sun","year":"2022","journal-title":"Adv. Sci."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153656_bib88","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/HEP.0000000000000369","article-title":"Epigenetic regulation of HBV-specific tumor-infiltrating T cells in HBV-related HCC","volume":"78","author":"You","year":"2023","journal-title":"Hepatology (Baltimore, Md"},{"issue":"3","key":"10.1016\/j.bbrc.2026.153656_bib89","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2017.06.007","article-title":"Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features","volume":"153","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib90","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/gutjnl-2021-325918","article-title":"Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification","volume":"72","author":"Montironi","year":"2023","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.bbrc.2026.153656_bib91","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","article-title":"Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing","volume":"169","author":"Zheng","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib92","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2021.08.029","article-title":"Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B","volume":"76","author":"Gao","year":"2022","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.bbrc.2026.153656_bib93","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.immuni.2021.06.013","article-title":"Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma","volume":"54","author":"Cheng","year":"2021","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.bbrc.2026.153656_bib94","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153656_bib95","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.it.2015.02.008","article-title":"Overcoming T cell exhaustion in infection and cancer","volume":"36","author":"Pauken","year":"2015","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.bbrc.2026.153656_bib96","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.bbrc.2026.153656_bib97","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"Boni","year":"2007","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153656_bib98","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jhep.2014.07.005","article-title":"Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation","volume":"61","author":"Bengsch","year":"2014","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153656_bib99","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2009.09.052","article-title":"Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B","volume":"138","author":"Fisicaro","year":"2010","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.bbrc.2026.153656_bib100","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s00262-019-02426-5","article-title":"PD-1+ TIGIT+ CD8+ T cells are associated with pathogenesis and progression of patients with hepatitis B virus-related hepatocellular carcinoma","volume":"68","author":"Liu","year":"2019","journal-title":"Cancer Immunol. Immunother. : CII"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib101","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ni.1674","article-title":"The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells","volume":"10","author":"Yu","year":"2009","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.bbrc.2026.153656_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047648","article-title":"Upregulation of the Tim-3\/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection","volume":"7","author":"Nebbia","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.bbrc.2026.153656_bib103","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni1271","article-title":"The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity","volume":"6","author":"Zhu","year":"2005","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153656_bib104","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/hep.25777","article-title":"Tim-3\/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma","volume":"56","author":"Li","year":"2012","journal-title":"Hepatology (Baltimore, Md"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib105","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cell.2017.06.007","article-title":"De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation","volume":"170","author":"Ghoneim","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bbrc.2026.153656_bib106","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","article-title":"Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses","volume":"162","author":"Chiappinelli","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib107","first-page":"32","article-title":"Heterogeneity of intratumoral microbiota within the tumor microenvironment and relationship to tumor development","volume":"1","author":"Gao","year":"2025","journal-title":"Media Res."},{"key":"10.1016\/j.bbrc.2026.153656_bib108","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2147\/HMER.S291976","article-title":"Current perspectives on nucleos(t)ide analogue therapy for the long-term treatment of hepatitis B virus","volume":"14","author":"Broquetas","year":"2022","journal-title":"Hepatic Med."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153656_bib109","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2015.11.035","article-title":"PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy","volume":"64","author":"Papatheodoridis","year":"2016","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153656_bib110","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jhep.2023.05.023","article-title":"Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: results from randomized clinical trials","volume":"79","author":"Gane","year":"2023","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153656_bib111","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jhep.2024.03.046","article-title":"JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: REEF-2","volume":"81","author":"Agarwal","year":"2024","journal-title":"J. Hepatol."},{"issue":"21","key":"10.1016\/j.bbrc.2026.153656_bib112","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1056\/NEJMoa2210027","article-title":"Efficacy and safety of Bepirovirsen in chronic hepatitis B infection","volume":"387","author":"Yuen","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bbrc.2026.153656_bib113","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S2468-1253(21)00176-X","article-title":"Safety, pharmacokinetics, and antiviral activity of RO7049389, a core protein allosteric modulator, in patients with chronic hepatitis B virus infection: a multicentre, randomised, placebo-controlled, phase 1 trial","volume":"6","author":"Yuen","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"10088","key":"10.1016\/j.bbrc.2026.153656_bib114","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1470-2045(21)00604-5","article-title":"Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial","volume":"23","author":"Yau","year":"2022","journal-title":"Lancet Oncol."},{"issue":"20","key":"10.1016\/j.bbrc.2026.153656_bib116","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.bbrc.2026.153656_bib117","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100070","article-title":"Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma","volume":"1","author":"Abou-Alfa","year":"2022","journal-title":"NEJM Evid."},{"issue":"7","key":"10.1016\/j.bbrc.2026.153656_bib118","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S1470-2045(15)00050-9","article-title":"Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial","volume":"16","author":"Zhu","year":"2015","journal-title":"Lancet Oncol."},{"issue":"27","key":"10.1016\/j.bbrc.2026.153656_bib119","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1200\/JCO.2011.41.2395","article-title":"Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I\/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo phase II consortium and the cancer therapeutics Re","volume":"30","author":"Yeo","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153656_bib120","article-title":"BET inhibitor suppresses migration of human hepatocellular carcinoma by inhibiting SMARCA4","volume":"11","author":"Choi","year":"2021","journal-title":"Sci. Rep."},{"issue":"7536","key":"10.1016\/j.bbrc.2026.153656_bib121","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nature14136","article-title":"Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex","volume":"517","author":"Konermann","year":"2014","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bbrc.2026.153656_bib122","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1182\/blood.2022016204","article-title":"Genome-edited allogeneic donor \u2018universal\u2019 chimeric antigen receptor T cells","volume":"141","author":"Qasim","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2026.153656_bib123","doi-asserted-by":"crossref","DOI":"10.2174\/0118761429310703240823045808","article-title":"Mechanism, potential, and concerns of immunotherapy for hepatocellular carcinoma and liver transplantation","volume":"17","author":"Sensi","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153656_bib124","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/0113892029313473240919105819","article-title":"CDT1 is a potential therapeutic target for the progression of NAFLD to HCC and the exacerbation of cancer","volume":"26","author":"He","year":"2025","journal-title":"Curr. Genom."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26004201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26004201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:29:56Z","timestamp":1793597396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26004201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":124,"alternative-id":["S0006291X26004201"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153656","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic rewiring and T cell exhaustion in HBV-induced HCC with implications for precision therapies","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153656","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153656"}}